Where's the rabbit?! I just noticed that disussion with potential partners for TFC-1067 global rights seems to have started in March/April according to previous investor presentations. This change of direction seems to be tied to excellent clinical trial results of the 0.4 percent concentration.
In parallell the lower concentration is available for local deals.
Let's see if there's a rabbit in the hat before the end of this month.